Combination Product Sponsors Get Extra Year for Postmarket Safety Compliance

Drug Industry Daily
A A
The FDA gave sponsors of combination drug/device products another year to get their IT affairs in order before complying with new postmarket safety reporting requirements.

To View This Article:

Login

Subscribe To Drug Industry Daily